DOJ Accuses Russian Intel Ring Of Plotting Murder On American Soil

Estradiol Hormone Patch Shortage Strains Pharmacies After Warning Lifted Authored by Jill McLaughlin via The Epoch Times, Some U.S. pharmacies are scrambling to fill estradiol transdermal patch prescriptions as demand for the menopause treatment continues to soar following the Trump administration’s decision to remove what it determined was an outdated cancer warning. “Manufacturers have been unable to provide sufficient supply of hormone replacement therapies [HRT] over the last several weeks,” CVS pharmacy spokeswoman Roslyn Guarino told The Epoch Times March 9. In November, the Food and Drug Administration (FDA) started the process of...

Entering The Gates Of Lies: Unmasking The Climate Version Of Theranos Authored by Sydney Rodman via RealClearEnergy, One of President Trump's campaign promises was eliminating climate scams. As net-zero climate policies fade into the shadows, another climate scam is biting the dust. Bill Gates's daughter, Phoebe Gates, may not have her father's entrepreneurial talent, but she, too, frequently peddles climate alarmism. Mr. Gates, however, renounced climate doomerism last year in a widely-shared memo. A recent media investigation determined the younger Gates and her cofounder, climate influencer Sophia Kianni's self-described sustainable e-commerce startup, Phia,...

RTX Boosts Outlook Again As Missile Demand Fuels Rearmament Supercycle RTX Corp., formerly Raytheon Technologies, raised its full-year outlook for a third straight quarter as the Western rearmament supercycle gathers momentum. Wall Street welcomed the earnings update: RBC Capital Markets called the results "strong," Goldman Sachs highlighted a "solid quarter" with higher guidance, and UBS pointed to "accelerating defense growth." The Tomahawk cruise missile maker reported third-quarter earnings earlier and now expects 2026 adjusted earnings of $7.65 to $7.75 a share, up from a previous ceiling of $7.25. Even the lower end...